Palvella Therapeutics (PVLA) Operating Margin Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) Operating Margin Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -10,520.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -254,718.00 |
| Dec 31, 2023 | 792,996.00 |
| Sep 30, 2023 | 465,579.00 |
| Jun 30, 2023 | 537,116.00 |
| Mar 31, 2023 | -70,383.00 |
| Dec 31, 2022 | -827,776.00 |
| Sep 30, 2022 | -424,766.00 |
| Jun 30, 2022 | -311,107.00 |
| Mar 31, 2022 | -2,895.00 |
| Dec 31, 2021 | -48,136.00 |
| Sep 30, 2021 | 3,561.00 |
| Jun 30, 2021 | -220,721.00 |
| Mar 31, 2021 | -984.00 |
| Dec 31, 2020 | 35,879.00 |
| Sep 30, 2020 | -48,497.00 |
| Jun 30, 2020 | 18,678.00 |
| Mar 31, 2020 | 9,594.00 |
| Dec 31, 2019 | 210,030.00 |
| Sep 30, 2019 | 7,426.00 |
| Jun 30, 2019 | -21,018.00 |